BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 16892160)

  • 1. The Genetic Basis of Type 2 Diabetes.
    Das SK; Elbein SC
    Cellscience; 2006 Apr; 2(4):100-131. PubMed ID: 16892160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to type 2 diabetes among Asian Indians.
    Radha V; Mohan V
    Indian J Med Res; 2007 Mar; 125(3):259-74. PubMed ID: 17496355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of type 2 diabetes mellitus].
    Guillausseau PJ; Laloi-Michelin M
    Rev Med Interne; 2003 Nov; 24(11):730-7. PubMed ID: 14604750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance, diabetes, and the adipocyte.
    Stolar MW
    Am J Health Syst Pharm; 2002 Dec; 59 Suppl 9():S3-8. PubMed ID: 12489380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Kruppel-like factor 7 regulates adipocytokine gene expressions in human adipocytes and inhibits glucose-induced insulin secretion in pancreatic beta-cell line.
    Kawamura Y; Tanaka Y; Kawamori R; Maeda S
    Mol Endocrinol; 2006 Apr; 20(4):844-56. PubMed ID: 16339272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin: Probe of the molecular paradigm associating diabetes and obesity.
    Ghoshal K; Bhattacharyya M
    World J Diabetes; 2015 Feb; 6(1):151-66. PubMed ID: 25685286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion.
    Ali S; Nafis S; Kalaiarasan P; Rai E; Sharma S; Bamezai RN
    Rev Diabet Stud; 2016; 13(1):17-34. PubMed ID: 27563694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Diabetes: An Updated Overview.
    Ghasemi A; Norouzirad R
    Crit Rev Oncog; 2019; 24(3):213-222. PubMed ID: 32422019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What role do fat cells play in pancreatic tissue?
    Gerst F; Wagner R; Oquendo MB; Siegel-Axel D; Fritsche A; Heni M; Staiger H; Häring HU; Ullrich S
    Mol Metab; 2019 Jul; 25():1-10. PubMed ID: 31113756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes.
    DiStefano JK
    Rev Diabet Stud; 2015; 12(3-4):260-76. PubMed ID: 26859655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
    Meece J
    Curr Med Res Opin; 2007 Apr; 23(4):933-44. PubMed ID: 17407650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.